Research ArticleOriginal Article
Open Access

Diagnostic performance of bone metabolic indexes for the detection of stroke

Li-Ming Tan, Lu Wang, Juan-Juan Chen, Hua Li and Wen-bo Luo
Saudi Medical Journal January 2017, 38 (1) 30-35; DOI: https://doi.org/10.15537/smj.2017.1.15813

References

  1. ↵
    1. Gonzalez-Parra E,
    2. Rojas-Rivera J,
    3. Tuñón J,
    4. Praga M,
    5. Ortiz A,
    6. Egido J
    (2012) Vitamin D receptor activation and cardiovascular disease. Nephrol Dial Transplant 27:17–21.
    OpenUrl
  2. ↵
    1. Sun Q,
    2. Pan A,
    3. Hu FB,
    4. Manson JE,
    5. Rexrode KM
    (2012) 25-hydroxyvitamin D levels and risk of stroke: A prospective study and meta-analysis. Stroke 43:1470–1477.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Daubail B,
    2. Jacquin A,
    3. Guilland JC,
    4. Khoumri C,
    5. Aboa-Eboulé C,
    6. et al.
    (2014) Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc Dis 37:367–364.
    OpenUrl
  4. ↵
    1. Skaaby T,
    2. Husemoen LL,
    3. Pisinger C,
    4. Jørgensen T,
    5. Thuesen BH,
    6. Fenger M,
    7. et al.
    (2013) 17 Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocine 43:618–625.
    OpenUrl
  5. ↵
    1. Kunutsor SK,
    2. Bakker SJ,
    3. Kootstra-Ros JE,
    4. Gansevoort RT,
    5. Gregson J,
    6. Dullaart RP
    (2015) Serum Alkaline Phosphatase and risk of incident cardiovascular disease: Interrelationship with high sensitivity C-Reactive protein. PLoS One 10:e0132822.
    OpenUrl
  6. ↵
    1. Sacco RL,
    2. Kasner SE,
    3. Broderick JP,
    4. Caplan LR,
    5. Connors JJ,
    6. Culebras A,
    7. et al.
    (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:2064–2089.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Hossein-Nezhad A,
    2. Holick MF
    (2013) Vitamin D for Health: A Global Perspective. Mayo Clin Proc 88:720–755.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Judd SE,
    2. Morgan CJ,
    3. Panwar B,
    4. Howard VJ,
    5. Wadley VG,
    6. Jenny NS,
    7. et al.
    (2016) Vitamin D deficiency and incident stroke risk in community-living black and white adults. Int J Stroke 11:93–102.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Carrelli AL,
    2. Walker MD,
    3. Lowe H,
    4. McMahon DJ,
    5. Rundek T,
    6. Sacco RL,
    7. et al.
    (2011) Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan Study. Stroke 42:2240–2245.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Chaudhuri JR,
    2. Mridula KR,
    3. Alladi S,
    4. Anamika A,
    5. Umamahesh M,
    6. Balaraju B
    (2014) Serum 25-Hydroxyvitamin D Deficiency in Ischemic Stroke and Subtypes in Indian Patients. J Stroke 16:44–50.
    OpenUrl
  11. ↵
    1. Blondon M,
    2. Sachs M,
    3. Hoofnagle AN,
    4. Ix JH,
    5. Michos ED,
    6. Korcarz C
    (2013) 25-hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 33:2639–2645.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Chowdhury R,
    2. Stevens S,
    3. Ward H,
    4. Chowdhury S,
    5. Sajjad A,
    6. Franco OH
    (2012) Circulation vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol 27:581–591.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Lee HB,
    2. Kim J,
    3. Kim SH,
    4. Kim S,
    5. Kim OJ,
    6. Oh SH
    (2015) Association between Serum Alkaline Phosphatase Level and Cerebral Small Vessel Disease. PLoS One 10:e0143355.
    OpenUrl
  14. ↵
    1. Li J,
    2. Gui L,
    3. Wu C,
    4. Yang B,
    5. Dai X,
    6. Deng Q
    (2013) Genome-wide association study on serum alkaline phosphatase levels in a Chinese population. BMC Genomics 14:684.
    OpenUrl
  15. ↵
    1. Liu J,
    2. Wang D,
    3. Li J,
    4. Xiong Y,
    5. Liu B,
    6. Wei C,
    7. et al.
    (2016) Increased serum Alkaline Phosphatase as a predictor of symptomatic hemorrhagic transformation in ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease. J Stroke Cerebrovasc Dis 7:s1052–3057.
    OpenUrl
  16. ↵
    1. Pratibha S,
    2. Praveen-Kumar S,
    3. Agadi JB
    (2014) Increased serum alkaline phosphatase and serum phosphate as predictors of mortality after stroke. Lin Diagn Res 8:CC01–3.
    OpenUrl
  17. ↵
    1. Shimizu Y,
    2. Imano H,
    3. Ohira T,
    4. Kitamura A,
    5. Kiyama M,
    6. Okada T
    (2013) Alkaline phosphatase and risk of stroke among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Stroke Cerebrovasc Dis 22:1046–1055.
    OpenUrl
  18. ↵
    1. Korada SK,
    2. Zhao D,
    3. Gottesman RF,
    4. Guallar E,
    5. Lutesy PL,
    6. Alonse A,
    7. et al.
    (2016) Panrathroid hormone and subclinical cerebrovascular disease: The atherosclerosis risk in communities brain magnetic resonace imaging study. Stroke Cerebrocasc Dis 25:883–893.
    OpenUrl
  19. ↵
    1. Kumar A,
    2. Singh S
    (2015) Parathyroidectomy Ameliorates Glucose and Blood Pressure Control in a Patient with Primary Hyperparathyroidism, Type 2 Diabetes, and Hypertension. Clin Med Insights Endocrinol Diabetes 8:63–66.
    OpenUrl
  20. ↵
    1. Bosworth C,
    2. Sachs MC,
    3. Duprez D,
    4. Hoofnagle AN,
    5. Ix JH,
    6. Jacobs DR
    (2013) Parathyroid hormone and arterial dysfunction in the Multi-Ethnic Study of Atherosclerosis. Clin Endocrinol (Oxf) 79:429–436.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Verheyen ND,
    2. Kienreich K,
    3. Gaksch M,
    4. van Ballegooijen AJ,
    5. Grubler MR,
    6. Hartaigh BO
    (2016) Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study. J Clin Hypertens (Greenwich) 18:543–550.
    OpenUrl
  22. ↵
    1. Van der Walt I,
    2. Swanepoel CR,
    3. Mahala B,
    4. Meyers AM
    (2015) Important complications of chronic kidney disease. S Afr Med J 105:2682.
    OpenUrl
  23. ↵
    1. Custodio MR,
    2. Koike MK,
    3. Neves KR,
    4. Do Reis LM,
    5. Graciolli FG,
    6. Neves CL
    (2012) Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system. Nephrol Dial Transplant 27:1437–1445.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Pal SN,
    2. Rush C,
    3. Parr A,
    4. Van Campenhout A,
    5. Golledge J
    (2010) Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis 210:88–93.
    OpenUrlPubMed
  25. ↵
    1. Shripad NP,
    2. Paula C,
    3. Jonathan G
    (2011) Circulating concentration of stem-cell-mobilizing cytokines are associated with levels of osteoprogenitor cells and aortic calcification secerity. Circ J 75:1227–1234.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Yamashita T,
    2. Okano K,
    3. Tsuruta Y,
    4. Akiba T,
    5. Nitta K
    (2013) Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients. Int Urol Nephol 45:207–214.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section